What is the fair value of McKesson Corporation (NYSE-MCK) stock?

The current fair value estimate for McKesson Corporation (NYSE-MCK) is $1,059. This implies an estimated upside of 21.0% versus the current market price.

Is McKesson Corporation (NYSE-MCK) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 21.0% versus the current market price.

What is the analyst price target for NYSE-MCK stock?

The available analyst price target for McKesson Corporation (NYSE-MCK) is $980.73. The analyst target implies estimated upside of 12.1%.

How is the financial health of McKesson Corporation?

The current financial health read for McKesson Corporation (NYSE-MCK) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is McKesson Corporation's next earnings date?

The next earnings date currently listed for McKesson Corporation (NYSE-MCK) is November 3, 2026.

Does McKesson Corporation (NYSE-MCK) pay dividends?

Based on the current data, dividend yield is 0.4%, payment date is October 1, 2026.

What is the P/E ratio for McKesson Corporation (NYSE-MCK)?

The current P/E ratio listed for McKesson Corporation (NYSE-MCK) is 22.3x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of McKesson Corporation?

The current market capitalization listed for McKesson Corporation is 102 B.

What is the enterprise value of McKesson Corporation?

The current enterprise value listed for McKesson Corporation is 112.1 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for McKesson Corporation?

The ticker symbol for McKesson Corporation is NYSE-MCK, and the stock is listed on NYSE.

Where is McKesson Corporation (NYSE-MCK) listed?

McKesson Corporation (NYSE-MCK) is listed on NYSE.

What is the debt-to-total-capital ratio for McKesson Corporation?

The current debt-to-total-capital ratio listed for McKesson Corporation is 10.1%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for McKesson Corporation?

The free float listed for McKesson Corporation is 99.8%. Free float helps investors understand how much of the share base is available for public trading.

McKesson Corporation (MCK) Fair Value & Stock Analysis

McKesson Corporation (MCK)

McKesson Corporation is a healthcare services company listed on the NYSE under the ticker MCK. As a common equity security, it represents ownership in the company, which serves customers in the United States and internationally. McKesson operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, Medical-Surgical Solutions, and International.

Its U.S. Pharmaceutical business distributes branded, generic, specialty, biosimilar, and over-the-counter medicines, along with related healthcare products, while also providing practice management, technology, clinical support, and business solutions for community-based oncology and other specialty practices. The Prescription Technology Solutions segment supports biopharma and life sciences partners with services that connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Medical-Surgical Solutions supplies healthcare providers with medical and surgical products, logistics, and related services. The International segment provides medicines, supplies, information technology solutions, and distribution services across multiple healthcare settings. McKesson was founded in 1833 and is headquartered in Irving, Texas.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Dividend Payment Date	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NYSE-MCK	$1,059	21.0% Upside	Undervalued	$980.73	12.1% Upside	Fair	Great	October 1, 2026	0.4%	November 3, 2026	22.3x	0.2x	102 B	112.1 B	10.1%	99.8%	6.9	8.6%	139.7%